Medicina
Departamento
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan–Ann Arbor (90)
2024
-
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study
Future oncology (London, England), Vol. 20, Núm. 6, pp. 297-306
-
Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease
Biomedicines, Vol. 12, Núm. 2
2023
-
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study
Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E995-E1003
-
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7
2022
-
Artificial intelligence analysis of the impact of fibrosis in arrhythmogenesis and drug response
Frontiers in Physiology, Vol. 13
-
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
The Lancet Haematology, Vol. 9, Núm. 1, pp. e14-e25
-
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
Nature Medicine, Vol. 28, Núm. 8, pp. 1640-1645
-
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Nature communications, Vol. 13, Núm. 1, pp. 1878
-
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Annals of Oncology, Vol. 33, Núm. 11, pp. 1168-1178
2021
-
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
New England Journal of Medicine, Vol. 385, Núm. 25, pp. 2336-2347
-
Electrocardiographic Imaging for Atrial Fibrillation: A Perspective From Computer Models and Animal Experiments to Clinical Value
Frontiers in Physiology, Vol. 12
-
Exercise Interventions to Prevent and Improve Sarcopenia
Sarcopenia: Second Edition (wiley), pp. 305-333
-
Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study
The Lancet Rheumatology, Vol. 3, Núm. 12, pp. e844-e854
-
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: A report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working Group
BMJ Open, Vol. 11, Núm. 11
2020
-
MiR130b from Schlafen4 + MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer
Gut, Vol. 69, Núm. 10, pp. 1750-1761
-
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial
Cancer, Vol. 126, Núm. 18, pp. 4156-4167
-
Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
Frontiers in Pediatrics, Vol. 8
-
Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrial fibrillation: An individual patient data meta-analysis
Heart Rhythm, Vol. 17, Núm. 8, pp. 1232-1240
-
The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval
Scientific Reports, Vol. 10, Núm. 1
-
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 10, pp. 963-974